Literature DB >> 17343595

Successful treatment of perianal Bowen's disease with imiquimod.

Sylvia van Egmond1, Carlijn Hoedemaker, Rodney Sinclair.   

Abstract

Although perianal Bowen's disease (BD) is a relatively uncommon malignancy, it is being detected with increasing frequency. It has a strong tendency for local recurrence and treatment remains controversial. The effectiveness of different treatment modalities, ranging from aggressive wide local excision with skin grafting to the application of a topical immune response modifier, remains uncertain. To our knowledge only two cases of perianal BD, successfully treated with imiquimod, have been reported. We wish to present the third case, effectively treated with imiquimod.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17343595     DOI: 10.1111/j.1365-4632.2007.03200.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  10 in total

1.  Bowen's disease: A favorable response to imiquimod.

Authors:  Prachi Barad; Joycelin Fernandes; Pankaj Shukla
Journal:  Indian Dermatol Online J       Date:  2014-10

2.  Nonsurgical innovations in the treatment of nonmelanoma skin cancer.

Authors:  Sadegh Amini; Martha H Viera; Whitney Valins; Brian Berman
Journal:  J Clin Aesthet Dermatol       Date:  2010-06

3.  Routine Treatment of Cervical Cytological Cell Changes: Diagnostic Standard, Prevention and Routine Treatment of Cervical Cytological Cell Changes - An Assessment of Primary and Secondary Prevention and Routine Treatment Data in the Context of an Anonymous Data Collection from Practicing Gynaecologists; an Academic, Non-Interventional Study.

Authors:  J Huber; B Pötsch; M Gantschacher; M Templ
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-10       Impact factor: 2.915

4.  Analysis of cellular and behavioral responses to imiquimod reveals a unique itch pathway in transient receptor potential vanilloid 1 (TRPV1)-expressing neurons.

Authors:  Se-Jeong Kim; Goon Ho Park; Donghoon Kim; Jaekwang Lee; Hyejung Min; Estelle Wall; C Justin Lee; Melvin I Simon; Sung Joong Lee; Sang-Kyou Han
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-07       Impact factor: 11.205

5.  Imiquimod enhances excitability of dorsal root ganglion neurons by inhibiting background (K(2P)) and voltage-gated (K(v)1.1 and K(v)1.2) potassium channels.

Authors:  Jaekwang Lee; Taekeun Kim; Jinpyo Hong; Junsung Woo; Hyunjung Min; Eunmi Hwang; Sung Joong Lee; C Justin Lee
Journal:  Mol Pain       Date:  2012-01-11       Impact factor: 3.395

6.  Synthesis of indole-cycloalkyl[b]pyridine hybrids via a four-component six-step tandem process.

Authors:  Muthumani Muthu; Rakkappan Vishnu Priya; Abdulrahman I Almansour; Raju Suresh Kumar; Raju Ranjith Kumar
Journal:  Beilstein J Org Chem       Date:  2018-11-22       Impact factor: 2.883

7.  R848 Is Involved in the Antibacterial Immune Response of Golden Pompano (Trachinotus ovatus) Through TLR7/8-MyD88-NF-κB-Signaling Pathway.

Authors:  Yongcan Zhou; Xiaojuan Chen; Zhenjie Cao; Jianlong Li; Hao Long; Ying Wu; Zhengshi Zhang; Yun Sun
Journal:  Front Immunol       Date:  2021-01-18       Impact factor: 7.561

8.  Environmental scan of anal cancer screening practices: worldwide survey results.

Authors:  Jigisha Patel; Irving E Salit; Michael J Berry; Alexandra de Pokomandy; Mayura Nathan; Fred Fishman; Joel Palefsky; Jill Tinmouth
Journal:  Cancer Med       Date:  2014-04-16       Impact factor: 4.452

Review 9.  Toll-like receptors and prostate cancer.

Authors:  Shu Zhao; Yifan Zhang; Qingyuan Zhang; Fen Wang; Dekai Zhang
Journal:  Front Immunol       Date:  2014-07-23       Impact factor: 7.561

Review 10.  Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy.

Authors:  Ruan F V Medrano; Aline Hunger; Samir Andrade Mendonça; José Alexandre M Barbuto; Bryan E Strauss
Journal:  Oncotarget       Date:  2017-07-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.